Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

R esearch at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe atopic dermatitis (eczema) in young children ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...

Studies show that there are few if any, additional side effects from the COVID-19 vaccine for people with eczema. In one ...

Medicare covers medically necessary treatment for eczema. This includes medicated creams and pills, dupilumab (Dupixent) injections, and phototherapy. Original Medicare with a Part D plan or an ...

These pivotal trial results strongly support the global approval of dupilumab in infants and children with eczema. It will revolutionise clinical practice worldwide Dr Peter Arkwright Follow me on X ...

These include Celgene’s Otezla, which is already approved for psoriasis, but is now also in development for eczema. Sanofi and Regeneron have an injectable drug Dupixent (dupilumab), but this ...

Sanofi’s Dupixent (dupilumab) has been cleared for NHS funding in Wales and Scotland in adolescents with severe eczema, also known as atopic dermatitis. The decisions from the All Wales ...

EADV 2024 Hand Eczema: Delgocitinib Takes on Established Treatments Topical delgocitinib appears more effective than oral alitretinoin and is comparable to dupilumab for treating types of hand ...

Further information NICE will not progress with an appraisal for this indication due to positive guidance in the adult population within TA534. NHS England and Improvement will commission treatments ...